Morphine modulates chemokine gene regulation in normal human astrocytes

Clinical Immunology

Volumn 115, Issue 3, 2005, Pages 323-332

  Mahajan, Supriya D ^a   Schwartz, Stanley A ^a   Aalinkeel, Ravikumar ^a   Chawda, Ram P ^a   Sykes, Donald E ^a   Nair, Madhavan P N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chemokine gene regulation; Human astrocytes; Morphine

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE ANTAGONIST;

ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ASTROCYTES; CELLS, CULTURED; CHEMOKINE CCL2; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MORPHINE; NALOXONE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, OPIOID, MU;

EID: 19144364834     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.02.004     Document Type: Article

References (48)

1. C. Gerard, and B.J. Rollins Chemokines and disease Nat. Immunol. 2 2 2001 108 115
2. R.C. Gallo, A.L. Garzino-Demo, and A.L. DeVico HIV infection and pathogenesis: what about chemokines? J. Clin. Immunol. 19 5 1999 293 299
3. A. Garzino-Demo, A.L. DeVico, F. Cocchi, and R.C. Gallo Beta-chemokines and protection from HIV type 1 disease AIDS Res. Hum. Retroviruses 14 Suppl. 2 1998 S177 S184
4. A. Garzino-Demo, A.L. DeVico, and R.C. Gallo Chemokine receptors and chemokines in HIV infection J. Clin. Immunol. 18 4 1998 243 255
5. V.C. Asensio, and I.L. Campbell Chemokines and viral diseases of the central nervous system Adv. Virus Res. 56 2001 127 173
6. M.E. Dorf, M.A. Berman, S. Tanabe, M. Heesen, and Y. Lou Astrocytes express functional chemokine receptors J. Neuroimmunol. 111 1-2 2000 109 121
7. E.J. Fernandez, and E. Lolis Structural studies of chemokines that inhibit HIV-1 entry Antiviral Chem. Chemother. 12 Suppl. 1 2001 43 49
8. A. Kinter, J. Arthos, C. Ciciala, and A.S. Fauci Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis Immunol. Rev. 177 2000 88 98
9. T.E. Lane, V.C. Asensio, N. Yu, A.D. Paoletti, I.L. Campbell, and M.J. Buchmeier Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease J. Immunol. 160 1998 970 978
10. O.M. Howard, J.J. Oppenheim, and J.M. Wang Chemokines as molecular targets for therapeutic intervention J. Clin. Immunol. 19 5 1999 280 292
11. A.E. Proudfoot, T.N. Wells, and P.R. Clapham Chemokine receptors-future therapeutic targets for HIV? Biochem. Pharmacol. 57 5 1999 451 463
12. T.S. Stantchev, and C.C. Broder Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors Cytokine Growth Factor Rev. 12 2-3 2001 219 243
13. J.P. Moore Coreceptors: implications for HIV pathogenesis and therapy Science 276 5309 1997 51 52
14. T. Mukakami, and N. Yamamoto Role of chemokines and chemokine receptors in HIV-1 infection Int. J. Hematol. 72 2000 412 417
15. W.S. Sheng, S. Hu, G. Gekker, S. Zhu, P.K. Peterson, and C.C. Chao Immunomodulatory role of opioids in the central nervous system Arch. Immunol. Ther. Exp. (Warsz.) 45 5-6 1997 359 366
16. W.E. Zink, J. Zheng, Y. Persidsky, L. Poluektova, and H.E. Gendelman The neuropathogenesis of HIV-1 infection FEMS Immunol. Med. Microbiol. 26 3-4 1999 233 241
17. A. Nath, K.F. Hauser, V. Wojna, R.M. Booze, W. Maragos, M. Prendergast, W. Cass, and J.T. Turchan Molecular basis for interactions of HIV and drugs of abuse J. Acquired Immune Defic. Syndr. 31 Suppl. 2 2002 S62 S69
18. S.A. Schwartz, and M.P.N. Nair Current concepts in human immunodeficiency virus infections and AIDS Clin. Diag. Lab. Immunol. 6 1999 295 305
19. M.P.N. Nair, S. Mahajan, K.C. Chadha, R. Hewitt, and S.A. Schwartz Immunopathogenesis of HIV infection. Role of recreational drugs Recent Res. Dev. Immunol. 1 1990 597 606
20. S.D. Mahajan, S.A. Schwartz, T.C. Shanahan, R.P. Chawda, and M.P.N. Nair Morphine regulates gene expression of α and β chemokines and their receptors on astroglial cells via the opioid μ receptor J. Immunol. 169 2002 3589 3599
21. I. Welters Opioids and immunosuppression. Clinical relevance? Anaesthesist 52 5 2003 442 452
22. J.E. Merrill, and I.S.Y. Chen HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease FASEB J. 5 1991 2391 2397
23. M.P.N. Nair, and S.A. Schwartz Immunopathogenesis of HIV infection, CNS-immune interactions Grant Martin Neuropsychology of HIV infection 1994 Oxford Univ. Press 41 55
24. J.P. Adams, E.D. Roberson, J.D. English, J.C. Selcher, and J.D. Sweatt MAPK regulation of gene expression in the central nervous system Acta Neurobiol. Exp. (Warsz.) 60 2000 377 394
25. P. Chomczynski, and N. Saachi Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
26. L. Shively, L. Chang, J.M. LeBon, Q. Liu, A.D. Riggs, J. Singer-Sam, Real-time PCR assay for quantitative mismatch detection. Biotechniques. 34(3) (2003) 498-502, 504.
27. J.E. Coligan A.M. Kruisbeek D.H. Margulies E.M. Shevach W. Strober Current protocols in immunology 1991 0-471-52276-7 145 186
28. G. Torres, and J.M. Horowitz Drugs of abuse and brain gene expression Psychosom. Med. 61 1999 630 650
29. A. Nath, and J.D. Geiger Neurobiological aspects of HIV infections: neurotoxic mechanisms Prog. Neurobiol. 54 1998 19 33
30. P.K. Peterson, G. Gekker, R. Schut, S. Hu, H.H. Balfour Jr., and C.C. Chao Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection Adv. Exp. Med. Biol. 335 1993 181 188
31. G.B. Stefano, B. Scharrer, E. Smith, T.K. Hughes, H.I. Magazine, T.V. Bilfinger, A.R. Hartman, G.L. Fricchione, Y. Liu, and M.H. Makman Opioids and opiate immunoregulatory processes Crit. Rev. Immunol. 16 1996 109 144
32. H.E. Gendelman, and M. Tardieu Macrophages/microglia and the pathophysiology of CNS injuries in AIDS J. Leukocyte Biol. 56 3 1994 387 388
33. P.T. Thomas, H.N. Bhargava, and R.V. House Immunomodulatory effects of in vitro exposure to morphine and its metabolites Pharmacology 50 1995 51 62
34. T. Lehner The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection Trends Immunol. 23 7 2002 347 351
35. G. Scarlatti, E. Tresoldi, A. Bjorndal, R. Fredriksson, C. Colognesi, H.K. Deng, M.S. Malnati, A. Plebani, A.G. Siccardi, D.R. Littman, E.M. Fenyo, and P. Lusso In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression Nat. Med. 3 11 1997 1259 1265
36. C.J. Guo, Y. Li, S. Tian, X. Wang, S.D. Douglas, and W.Z. Ho Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor J. Invest. Med. 50 6 2002 435 442
37. Y. Miyamoto, and S.u. Kim Cytokine-induced production of macrophage inflammatory protein-1 alpha (MIP-1alpha) in cultured human astrocytes J. Neurosci. Res. 55 2 1999 245 251
38. P.K. Peterson, S. Hu, J. Salak-Johnson, T.W. Molitor, and C.C. Chao Differential production of and migratory response to beta chemokines by human microglia and astrocytes J. Infect. Dis. 175 2 1997 478 481
39. M.H. Makman Morphine receptors in immunocytes and neurons Adv. Neuroimmunol. 4 2 1994 69 82
40. R.D. Polakiewicz, S.M. Schieferl, A.C. Gingras, N. Sonenberg, and M.J. Comb mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control J. Biol. Chem. 73 36 1998 23534 23541
41. R.D. Polakiewicz, S.M. Schieferl, L.F. Dorner, V. Kansra, and M.J. Comb A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization J. Biol. Chem. 273 20 1998 12402 12406
42. J.S. Gutkind The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades J. Biol. Chem. 273 4 1998 1839 1842
43. Y. Persidsky, M. Stins, D. Way, M.H. Witte, M. Weinand, K.S. Kim, P. Bock, H.E. Gendelman, and M. Fiala A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis J. Immunol. 158 7 1997 (Apr. 1) 3499 3510
44. S.X. Hu, C.C. Chao, C.C. Hegg, S. Thayer, and P.K. Peterson Morphine inhibits human microglial cell production of, and migration towards, RANTES J. Psychopharmacol. 14 2000 238 243
45. M.C. Grimm, A. Ben-Baruch, D.D. Taub, O.M. Howard, J.M. Wang, and J.J. Oppenheim Opiate inhibition of chemokine-induced chemotaxis Ann. N. Y. Acad. Sci. 840 1998 (May 1) 9 20
46. R. Vallejo, O. de Leon-Casasola, and R. Benyamin Opioid therapy and immunosuppression: a review Am. J. Ther. 11 5 2004 (Sep.-Oct.) 354 365
47. A. Nath, C. Anderson, M. Jones, W. Maragos, R. Booze, C. Mactutus, J. Bell, K.F. Hauser, and M. Mattson Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia J. Psychopharmacol. 14 2000 222 227
48. M.A Wetzel, A.D. Steele, T.K. Eisenstein, M.W. Adler, E.E. Henderson, and T.J. Rogers Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells J. Immunol. 165 2000 6519 6524